UPC_CFI_621/2025

Claimants

• GlaxoSmithKline Biologicals SA

Respondents

• C.P. Pharmaceuticals International C.V.
• Pfizer Export B.V.
• Pfizer B.V.
• Pfizer Manufacturing Belgium NV
• Pfizer Service Company B.V./S.r.l.
• Pfizer S.A./N.V.
• Pfizer Luxembourg S.a.r.l.
• Pfizer, Inc.
• Pfizer Corporation Austria Gesellschaft m.b.H
• Pfizer Aps
• Pfizer Oy
• Pfizer SAS
• Pfizer Pharma GmbH
• Pfizer S.r.l.
• Laboratórios Pfizer, Lda.
• Pfizer Romania S.R.L.
• Pfizer AB
• Pfizer, spol. S.r.o.
• Pfizer Hellas A.E.
• Pfizer, S.L.
• Pfizer Croatia d.o.o.
• Pfizer Gyógyszerkereskedelmi Kft.
• Pfizer Polska Sp. Z.o.o.
• Pfizer Trading Polska Sp. Z.o.o.
• Pfizer AG
• Pfizer AS
• BioNTech SE
• BioNTech Europe GmbH
• BioNTech Manufacturing GmbH
• BioNTech Manufacturing Marburg GmbH

• EP4226941
• EP4066856

Technology area: Biotech · mRNA Vaccine

Sector: Biotechnology